Literature DB >> 15372340

[Diagnosis and management of cervical paragangliomas: the Freiburg experience].

C C Boedeker1, G J Ridder, H P Neumann, W Maier, J Schipper.   

Abstract

BACKGROUND: Paragangliomas of the head and neck represent rare tumors of neural crest origin that arise from chemoreceptors. They are highly vascular neoplasms that are benign in the majority of cases. There are controversial discussions concerning the different treatment options for cervical paragangliomas. PATIENTS: Between January 1992 and November 2003 a total of 13 patients with 15 cervical paragangliomas were treated at the Department of Otorhinolaryngology - Head and Neck Surgery, University of Freiburg. Our study includes eight female and five male patients with a mean age of 39.9 years (range: 20 - 79 years). There were 14 carotid body tumors and one vagal paraganglioma.
RESULTS: 14 tumors were resected and one underwent primary radiation. In four patients we noted a total of 8 permanent, postoperative nerve deficits. During follow-up no recurrent tumors were seen.
CONCLUSION: Complete surgical removal represents the therapy of choice for the majority of cervical paragangliomas. In cases of multiple head and neck paragangliomas or in patients with underlying diseases, primary radiation should be discussed as a treatment option.

Entities:  

Mesh:

Year:  2004        PMID: 15372340     DOI: 10.1055/s-2004-814466

Source DB:  PubMed          Journal:  Laryngorhinootologie        ISSN: 0935-8943            Impact factor:   1.057


  4 in total

1.  [A young patient with paraganglioma syndrome type I. An interdisciplinary challenge].

Authors:  C Brase; H Neumann; M Lell; S Schwarz-Furlan; K Rogler; J Hornung
Journal:  HNO       Date:  2012-08       Impact factor: 1.284

2.  [Direct percutaneous embolization of a carotid body tumor with Onyx].

Authors:  S Ulrich; M Lehmann; J Ebmeyer; U Hamberger; U Reineke; U Dietrich; H Sudhoff
Journal:  HNO       Date:  2009-12       Impact factor: 1.284

3.  Carotid body tumors: objective criteria to predict the Shamblin group on MR imaging.

Authors:  S Arya; V Rao; S Juvekar; A K Dcruz
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-16       Impact factor: 3.825

4.  Paragangliomas and paraganglioma syndromes.

Authors:  Carsten Christof Boedeker
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.